X
Xenon Pharmaceuticals
Biotech & Life Sciences · Burnaby, Canada · Founded 1996 · IPO 2014
From families to genes, from genes to drugs. MoreLess
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to address neurological disorders. The company operates primarily in the healthcare and pharmaceutical markets, targeting conditions such as epilepsy and other central nervous system disorders. Xenon's business model revolves around the research, development, and commercialization of novel therapies. Revenue is generated through partnerships, licensing agreements, and potential future product sales. The company serves a diverse client base, including healthcare providers, patients, and research institutions. Xenon leverages its expertise in genetics and neurology to create a robust pipeline of drug candidates, currently highlighted by its Phase 2 proof of concept study for XEN007 in pediatric patients with treatment-resistant childhood absence epilepsy (CAE). The company's strategic focus on unmet medical needs and its commitment to advancing neurology therapies position it as a key player in the biopharmaceutical industry.
Keywords: neurology, epilepsy, therapeutics, clinical-stage, biopharmaceutical, genetics, CNS disorders, drug development, healthcare, innovation.
Talent graph
Xenon Pharmaceuticals's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Xenon Pharmaceuticals has talent and traffic
team presence
across markets
Patent intelligence
$90M patent portfolio · 68 active families
Where Xenon Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Xenon Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Xenon Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Xenon Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Xenon Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.